Using simulation modeling to inform intervention and implementation selection in a rapid stakeholder-engaged hybrid effectiveness-implementation randomized trial

被引:0
|
作者
Becker, Jessica E. [1 ]
Shebl, Fatma M. [2 ,3 ]
Losina, Elena [3 ,4 ]
Wilson, Anna [5 ]
Levison, Julie H. [3 ,5 ,6 ]
Donelan, Karen [5 ,7 ]
Fung, Vicki [3 ,5 ]
Trieu, Hao [5 ]
Panella, Christopher [2 ]
Qian, Yiqi [2 ]
Kazemian, Pooyan [8 ]
Bird, Bruce [9 ]
Skotko, Brian G. [3 ,10 ]
Bartels, Stephen [3 ,5 ,6 ]
Freedberg, Kenneth A. [2 ,3 ,11 ,12 ]
机构
[1] NYU, Dept Child & Adolescent Psychiat, NYU Langone Hlth, Grossman Sch Med, One Pk Ave,Seventh Floor, New York, NY 10016 USA
[2] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA USA
[5] Massachusetts Gen Hosp, Mongan Inst, Boston, MA USA
[6] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[7] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA
[8] Case Western Reserve Univ, Weatherhead Sch Management, Dept Operat, Cleveland, OH USA
[9] Kennedy Krieger Inst, Dept Behav Psychol, Baltimore, MD USA
[10] Massachusetts Gen Hosp, Dept Pediat, Down Syndrome Program, Div Med Genet & Metab, Boston, MA USA
[11] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA USA
[12] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Boston, MA USA
来源
基金
美国医疗保健研究与质量局;
关键词
COST-EFFECTIVENESS; MEDICAL CONDITIONS; HEALTH; COVID-19; MORTALITY; SCIENCE; DESIGNS; IMPACT;
D O I
10.1186/s43058-024-00593-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Implementation research generally assumes established evidence-based practices and prior piloting of implementation strategies, which may not be feasible during a public health emergency. We describe the use of a simulation model of the effectiveness of COVID-19 mitigation strategies to inform a stakeholder-engaged process of rapidly designing a tailored intervention and implementation strategy for individuals with serious mental illness (SMI) and intellectual/developmental disabilities (ID/DD) in group homes in a hybrid effectiveness-implementation randomized trial.Methods We used a validated dynamic microsimulation model of COVID-19 transmission and disease in late 2020/early 2021 to determine the most effective strategies to mitigate infections among Massachusetts group home staff and residents. Model inputs were informed by data from stakeholders, public records, and published literature. We assessed different prevention strategies, iterated over time with input from multidisciplinary stakeholders and pandemic evolution, including varying symptom screening, testing frequency, isolation, contact-time, use of personal protective equipment, and vaccination. Model outcomes included new infections in group home residents, new infections in group home staff, and resident hospital days. Sensitivity analyses were performed to account for parameter uncertainty. Results of the simulations informed a stakeholder-engaged process to select components of a tailored best practice intervention and implementation strategy.Results The largest projected decrease in infections was with initial vaccination, with minimal benefit for additional routine testing. The initial level of actual vaccination in the group homes was estimated to reduce resident infections by 72.4% and staff infections by 55.9% over the 90-day time horizon. Increasing resident and staff vaccination uptake to a target goal of 90% further decreased resident infections by 45.2% and staff infections by 51.3%. Subsequent simulated removal of masking led to a 6.5% increase in infections among residents and 3.2% among staff. The simulation model results were presented to multidisciplinary stakeholders and policymakers to inform the "Tailored Best Practice" package for the hybrid effectiveness-implementation trial.Conclusions Vaccination and decreasing vaccine hesitancy among staff were predicted to have the greatest impact in mitigating COVID-19 risk in vulnerable populations of group home residents and staff. Simulation modeling was effective in rapidly informing the selection of the prevention and implementation strategy in a hybrid effectiveness-implementation trial. Future implementation may benefit from this approach when rapid deployment is necessary in the absence of data on tailored interventions.Trial registration ClinicalTrials.gov NCT04726371
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The role of stakeholder-engaged effectiveness-implementation hybrid designs in health care research: methodological challenges and opportunities through the lens of a case hybrid study
    Soukup, Tayana
    Hull, Louise
    Bakolis, Ioannis
    Healey, Andy
    Kariyawasam, Dulmini
    Brooks, Augustin
    Heller, Simon
    Amiel, Stephanie
    Sevdalis, Nick
    [J]. IMPLEMENTATION SCIENCE, 2020, 15 (SUPPL 4):
  • [2] Safety Huddle Intervention for Reducing Physiologic Monitor Alarms: A Hybrid Effectiveness-Implementation Cluster Randomized Trial
    Bonafide, Christopher P.
    Localio, A. Russell
    Stemler, Shannon
    Ahumada, Luis
    Dewan, Maya
    Ely, Elizabeth
    Keren, Ron
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2018, 13 (09) : 609 - 615
  • [3] Pragmatic randomized trial of a distress screening program using an effectiveness-implementation hybrid design.
    Hahn, Erin Elizabeth
    Munoz-Plaza, Corrine E.
    Pounds, Dana
    Lyons, Lindsay Joe
    Lee, Janet S.
    Shen, Ernest
    La Cava, Shannon
    Brasfield, Farah
    Durna, Lara N.
    Kwan, Karen W.
    Beard, David B.
    Ferreira, Alexander
    Schottinger, Joanne E.
    Mittman, Brian S.
    Gould, Michael K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [4] Study protocol: implementation of a computer-assisted intervention for autism in schools: a hybrid type II cluster randomized effectiveness-implementation trial
    Melanie Pellecchia
    Rinad S. Beidas
    Steven C. Marcus
    Jessica Fishman
    John R. Kimberly
    Carolyn C. Cannuscio
    Erica M. Reisinger
    Keiran Rump
    David S. Mandell
    [J]. Implementation Science, 11
  • [5] Study protocol: implementation of a computer-assisted intervention for autism in schools: a hybrid type II cluster randomized effectiveness-implementation trial
    Pellecchia, Melanie
    Beidas, Rinad S.
    Marcus, Steven C.
    Fishman, Jessica
    Kimberly, John R.
    Cannuscio, Carolyn C.
    Reisinger, Erica M.
    Rump, Keiran
    Mandell, David S.
    [J]. IMPLEMENTATION SCIENCE, 2016, 11
  • [6] Design of a dual randomized trial in a type 2 hybrid effectiveness-implementation study
    Stevens, June
    Mills, Sarah Denton
    Millett, Thomas J.
    Lin, Feng-Chang
    Leeman, Jennifer
    [J]. IMPLEMENTATION SCIENCE, 2023, 18 (01)
  • [7] The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting A Randomized, Effectiveness-Implementation Trial
    Patzer, Rachel E. E.
    Zhang, Rebecca
    Buford, Jade
    McPherson, Laura
    Lee, Yi-Ting Hana
    Urbanski, Megan
    Li, Dong
    Wilk, Adam
    Paul, Sudeshna
    Plantinga, Laura
    Escoffery, Cam
    Pastan, Stephen O. O.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (03): : 374 - 382
  • [8] Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial
    Becker, Sara J.
    Murphy, Cara M.
    Hartzler, Bryan
    Rash, Carla J.
    Janssen, Tim
    Roosa, Mat
    Madden, Lynn M.
    Garner, Bryan R.
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [9] Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial
    Sara J. Becker
    Cara M. Murphy
    Bryan Hartzler
    Carla J. Rash
    Tim Janssen
    Mat Roosa
    Lynn M. Madden
    Bryan R. Garner
    [J]. Addiction Science & Clinical Practice, 16
  • [10] The unrecognized role of fidelity in effectiveness-implementation hybrid trials: simulation study and guidance for implementation researchers
    Trutschel, Diana
    Blatter, Catherine
    Simon, Michael
    Holle, Daniela
    Reuther, Sven
    Brunkert, Thekla
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)